McClellan Reinforces FDA Advertising Surveillance, Warning Letter Policy
This article was originally published in The Gray Sheet
Executive Summary
FDA remains committed to its vigilant oversight of direct-to-consumer advertising following a request for expedited handling of DTC ad warning letters by the General Accounting Office
You may also be interested in...
CDRH Promotion & Advertising Website Planned; DTC Guidance In Works
Device untitled letters could be easier to access in the coming months, once CDRH's planned promotion and advertising policy staff (PAPS) website is developed
CDRH Promotion & Advertising Website Planned; DTC Guidance In Works
Device untitled letters could be easier to access in the coming months, once CDRH's planned promotion and advertising policy staff (PAPS) website is developed
Paper Tigers Or Paper Bullets? FDA Curbs Repeat Warning Letters, Violations
Enforcement policies under way within FDA's Office of the Chief Counsel could eliminate the practice of issuing multiple compliance warning letters, according to agency officials